Enrique Aranda Aguilar

Profesor Titular de Universidad

Universidad de Córdoba

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Cancer Biology Cancer Biology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Enrique Aranda Aguilar is a Profesor Titular de Universidad at Universidad de Córdoba in Spain. His research interests include oncology, with a focus on breast and colorectal cancer treatments, as well as advancements in personalized medicine and biomarkers. Recent publications explore critical issues such as surgical prioritization in breast cancer, prognostic indices for brain metastases, and the implications of genetic factors in chemotherapy-related complications.

Articles (20)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (8)

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Enrique Aranda Aguilar

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Prioritizing breast cancer surgeries: insights from the KRONOS SCORE.

<i>Nab</i> -Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer

Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial.

Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study.

Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study.

A new updated prognostic index for patients with brain metastases (BMs) treated with palliative whole brain radiotherapy (WBRT) in the era of precision oncology. METASNCore project.

Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection.

Delphi consensus for the third-line treatment of metastatic colorectal cancer.

NeuroPredict: study of the predictive value of ABCB1 genetic polymorphisms and associated clinical factors in chronic chemotherapy-induced peripheral neuropathy (CIPN).

Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement

A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients

Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials

Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study

Metabolic shift underlies tumor progression and immune evasion in S-nitrosoglutathione reductase-deficient cancer

Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects.

Basal VEGF-A and ACE Plasma Levels of Metastatic Colorectal-Cancer Patients Have Prognostic Value for First-Line Treatment with Chemotherapy Plus Bevacizumab

A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)

Association of miR-21 and miR-335 to microsatellite instability and prognosis in stage III colorectal cancer

Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial

Anxiety, depression and quality of life: a longitudinal study involving cancer patient-caregiver dyads

Collaborators (8)

Álvaro Arjona-Sánchez

Francisco Garcia-Torres

VEGA IRANZO GONZALEZ-CRUZ

Garcia-Foncillas J

Ruth Vera

Juan Rafael de la Haba Rodríguez

Begoña Graña

Paula Jimenez-Fonseca

Make your next move.